文献
J-GLOBAL ID:202002220799824554
整理番号:20A0664873
新規血液悪性腫瘍特異的患者報告転帰測定(HM-Pro)の開発:内容妥当性【JST・京大機械翻訳】
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity
著者 (13件):
Goswami Pushpendra
(School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom)
,
Oliva Esther N.
(Haematology Unit, Grande Ospedale Metropolitano, Reggio Calabria, Italy)
,
Ionova Tatyana
(St. Petersburg State University Medical Center and Multinational Centre for Quality of Life Research, Saint Petersburg, Russia)
,
Else Roger
(Patient Research Partner, Milton Keynes, United Kingdom)
,
Kell Jonathan
(Cardiff and Vale University Health Board, Cardiff, United Kingdom)
,
Fielding Adele K.
(Cancer Institute, University College London, London, United Kingdom)
,
Jennings Daniel M.
(Royal Surrey NHS Foundation Trust, Guildford, United Kingdom)
,
Karakantza Marina
(Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom)
,
Al-Ismail Saad
(Singleton Hospital, ABM University Health Board, Swansea, United Kingdom)
,
Collins Graham P.
(Oxford University Hospital NHS Foundation Trust, Oxford, United Kingdom)
,
McConnell Stewart
(Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom)
,
Langton Catherine
(Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom)
,
Salek Sam
(School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom)
資料名:
Frontiers in Pharmacology (Web)
(Frontiers in Pharmacology (Web))
巻:
11
ページ:
209
発行年:
2020年
JST資料番号:
U7091A
ISSN:
1663-9812
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
スイス (CHE)
言語:
英語 (EN)